Marcy l’Etoile, France – bioMérieux, a world leader in the field of in vitro diagnostics, has signed an agreement to acquire AES Laboratoire, a leading French group, specialized in industrial microbiological control, for 183 million euros. This will be bioMérieux’s ninth acquisition in five years and its third in the area of industrial applications. Founded […]
Glasgow, Scotland – Renishaw Diagnostics Ltd, a world leading provider of trace level detection technologies based on the exploitation of surface enhanced Raman scattering (SERS) and surface enhanced resonance Raman scattering (SERRS), for research and molecular diagnostics applications, today announced that it has concluded an exclusive licence agreement to a patent on nucleic acid sequence […]
SUNNYVALE, Calif. – Cepheid (NASDAQ: CPHD) today announced it has entered into an agreement with LABSCO (www.labsco.com), the largest privately held distributor of clinical products in the United States, to become its US distribution partner for Cepheid’s GeneXpert? Systems and tests. The agreement grants LABSCO exclusive US distribution rights to the acute care hospital market […]
HERCULES, CA – Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the European and Canadian launch of its BioPlex® 2200 Antiphospholipid Syndrome IgG, IgM, and IgA kits for use on its BioPlex® 2200 system. Antiphospholipid Syndrome is an autoimmune disease in which the body’s immune […]
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that Proteomika S.L., subsidiary of Progenika Group, a Spanish biotechnology company specializing in biomarker discovery, has signed a commercial license agreement for seven diagnostic HuCAL-antibodies from MorphoSys’s AbD Serotec Division. To generate these antibodies AbD Serotec applied MorphoSys’s HuCAL GOLD and HuCAL PLATINUM antibody technologies. […]
LAVAL, QC – Roche Diagnostics Canada is pleased to announce the launch of the cobas® 8000 modular analyzer series. In parallel with the launch of this latest member of Roche’s “cobas” family of laboratory testing platforms, Roche Diagnostics Canada has completed the first North American installation of the cobas 8000 system at BC Biomedical Laboratories. […]
CARLSBAD, Calif. – Life Technologies Corporation (NASDAQ: LIFE), today announced that its 7500 Fast Dx Real-Time PCR Instrument and 3500 Dx Series Genetic Analyzer are now available platforms suitable for in vitro diagnostics (IVD) use in Japan. Both the 7500 Dx and 3500 Dx were filed as diagnostic application instruments to the Tokyo Metropolitan Government […]
AMSTERDAM and IRVINE, California – Agendia, an innovative molecular cancer diagnostics company, today announced that it has partnered with AstraZeneca and The Netherlands Cancer Institute (NKI) to accelerate the development of targeted therapies for colorectal cancer patients. The announcement marks a unique collaboration between Agendia, developer of the “MammaPrint” breast cancer molecular diagnostic test, a […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX) today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip® Microarray Instrument System for in vitro diagnostic (IVD) use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic […]
FREDERICK, MD. and SEOUL, KOREA – Akonni Biosystems and Seegene Inc. today announced that they have entered into a non-exclusive licensing agreement to develop both point-of-care and ultra-high throughput diagnostic screening assays capable of simultaneously detecting, from a single patient sample, a wide variety of infectious pathogens known to cause respiratory disease. The agreement brings […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
